4.7 Review

The role of microRNAs in depression

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

Circulating hsa-let-7e-5p and hsa-miR-125a-5p as Possible Biomarkers in the Diagnosis of Major Depression and Bipolar Disorders

Dovydas Gecys et al.

Summary: The study found that hsa-let-7e-5p and hsa-miR-125a-5p were upregulated in patients with MDD and BD, potentially serving as peripheral biomarkers for mood disorders. However, suicidal ideation remains the major diagnostic factor for both MDD and BD.

DISEASE MARKERS (2022)

Article Multidisciplinary Sciences

Corticosterone-mediated regulation and functions of miR-218-5p in rat brain

Yuta Yoshino et al.

Summary: Chronic stress is a key factor in major depressive disorder, and this study found that miR-218-5p plays a role in the mechanism of depression by inducing chromatin-based transcriptional changes of several CNS genes. The upregulation of miR-218-5p in response to chronic stress was observed in the prefrontal cortex of rats. This research provides insights into the potential therapeutic target of miR-218-5p in clinical depression.

SCIENTIFIC REPORTS (2022)

Article Neurosciences

Integrative Analysis of Long Non-coding RNAs, Messenger RNAs, and MicroRNAs Indicates the Neurodevelopmental Dysfunction in the Hippocampus of Gut Microbiota-Dysbiosis Mice

Lanxiang Liu et al.

Summary: This study investigates the role of the gut microbiota in major depressive disorder (MDD) and identifies dysregulated genes and pathways associated with MDD. The results show that dysbiosis of the gut microbiota leads to differential expression of mRNA, lncRNA, and miRNA in the hippocampus of mice. Functional analysis reveals that dysregulated inflammatory response and neurodevelopmental processes are key pathological changes in MDD. Moreover, a microbial-regulated lncRNA-miRNA-mRNA network is constructed, highlighting the potential genetic and epigenetic biomarkers for microbial-associated depression. This study sheds light on the pathogenesis of MDD and provides insights for the development of gut microbiota-based antidepressants.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2022)

Article Biotechnology & Applied Microbiology

Histone methyltransferase enhancer of zeste 2 polycomb repressive complex 2 subunit exacerbates inflammation in depression rats by modulating microglia polarization

Xuezhu Huang et al.

Summary: This experiment investigated the role of EZH2 in depression and found that EZH2 overexpression was involved in neuroinflammation. Silencing EZH2 reversed depression-like behaviors and inflammation. Furthermore, EZH2 regulated microglia polarization by targeting miR-29b-3p and MMP2 expression.

BIOENGINEERED (2022)

Article Neurosciences

Baiap3 regulates depressive behaviors in mice via attenuating dense core vesicle trafficking in subsets of prefrontal cortex neurons

Hyunwoo Kim et al.

Summary: This study found that BAIAP3 is significantly downregulated in mouse models of depression. The downregulation of BAIAP3 reduces trafficking of dense core vesicles and decreases 5-HT exocytosis and levels in the synapse, leading to defective post-synaptic neurotransmission. The study also identified eucalyptol as a potential therapy for depression, as it increases Baiap3 expression and restores serotonin levels.

NEUROBIOLOGY OF STRESS (2022)

Article Biology

Novel Pharmacological Approaches to the Treatment of Depression

Elias Elias et al.

Summary: This review discusses novel pharmacological targets for the treatment of major depressive disorder, including receptors and biological processes. Targeted drugs for certain receptors and compounds regulating inflammation, the hypothalamic-pituitary-adrenal axis, cholesterol, and gut microbiota show potential in treating depression. Natural products have also been found to improve depressive symptoms and behaviors.

LIFE-BASEL (2022)

Article Behavioral Sciences

Inhibition of TRPC1, TRPM4 and CHRNA6 ion channels ameliorates depression-like behavior in rats

Ilay Kavuran Buran et al.

Summary: The roles of ion channels, miRNAs, and neurotransmitters in major depressive disorder were investigated in a rat model. The study found that gene expressions of ion channels were upregulated in the hippocampus and prefrontal cortex, ion channel inhibitors exhibited antidepressant effects, and neurotransmitter levels were altered. Additionally, 6 miRNAs showed significant changes in expression in the brain.

BEHAVIOURAL BRAIN RESEARCH (2022)

Article Biotechnology & Applied Microbiology

Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression

Xian Xian et al.

Summary: This study found significantly higher expression levels of miR-9-5p in serum exosomes from patients with depression. Using experimental models, the researchers observed that miR-9-5p caused polarization of microglia and excessive release of inflammatory factors, exacerbating neuronal damage. The study also identified SOCS2 as a target of miR-9-5p. Overexpression of miR-9-5p suppressed SOCS2 expression and activated the JAK/STAT3 pathway. The findings suggest that the expression and secretion of miR-9-5p may serve as novel therapeutic targets for depression.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

Article Biotechnology & Applied Microbiology

MicroRNA-139-5p acts as a suppressor gene for depression by targeting nuclear receptor subfamily 3, group C, member 1

Bing Su et al.

Summary: The study revealed that the inhibition of miR-139-5p in depression can exert antidepressant-like effects by activating the BDNF-TrkB signaling pathway, suggesting its potential as an effective target for depression treatment.

BIOENGINEERED (2022)

Article Neurosciences

CircDYM ameliorates CUMS mice depressive-like behavior and inhibits hippocampal neurons injury via miR-497a-5p/NR3C1 axis

Xiao Li et al.

Summary: This study confirmed that circDYM could alleviate depressive-like behavior and hippocampal neurons injury in CUMS mice through the miR-497a-5p/NR3C1 pathway, suggesting circDYM as a potential target for depression treatment.

BRAIN RESEARCH (2022)

Article Mathematical & Computational Biology

Effects of miR-124-3p Silencing on Neuronal Damage in the Hippocampus of Depression Rats by Regulating STAT3 Gene

Guangping Qin et al.

Summary: Silencing miR-124-3p can protect hippocampal neurons from damage in depression rats by upregulating the STAT3 gene.

COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2022)

Review Neurosciences

Neuroinflammation and depression: A review

Romain Troubat et al.

Summary: Neuroinflammation interacts with key neurobiological factors of depression, potentially presenting a crucial therapeutic target for future treatments. This interaction may impact serotonin levels, HPA axis regulation, and hippocampal neurogenesis, leading to the pathophysiological cascade of increased glutamate levels and altered neurotransmission. It can be triggered by chronic inflammatory conditions or primary brain neuroinflammation, highlighting the importance of addressing neuroinflammation in the treatment of major depressive disorder.

EUROPEAN JOURNAL OF NEUROSCIENCE (2021)

Article Psychiatry

Association of circulating let-7b-5p with major depressive disorder: a nested case-control study

Sanne Roumans et al.

Summary: The study found that lower plasma levels of let-7b-5p are associated with a higher future risk of MDD. These results need validation in a large cohort to explore its potential as a peripheral biomarker for MDD.

BMC PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

Inflammatory proteins and miRNA-144-5p in patients with depression, anxiety, or stress- and adjustment disorders after psychological treatment

Kristina Sundquist et al.

Summary: This study examined the association between inflammatory proteins and miRNAs in patients with depression, anxiety, or stress- and adjustment disorders. After 8-week psychological treatments, a significant decrease in inflammatory proteins levels was observed, with some proteins showing an inverse correlation with miR-144-5p levels. Further studies are needed to clarify the relationship between protein levels and treatment response in these psychiatric disorders.

CYTOKINE (2021)

Article Biotechnology & Applied Microbiology

Circulating microRNAs and Molecular Oxidative Stress in Older Adults with Neuroprogression Disorders

Hadeel A. Al-Rawaf et al.

Summary: The study found that the expression levels of miR-124 and miR-34a-5p were significantly increased, while miR-135 and miR-451-a were significantly decreased in older adults with depression. Additionally, cortisol levels significantly increased and serotonin levels significantly reduced in depressed individuals. Cellular oxidative stress parameters were positively correlated with depression scores and cortisol levels, and negatively correlated with serotonin levels.

DISEASE MARKERS (2021)

Article Biochemistry & Molecular Biology

miR-323a regulates ERBB4 and is involved in depression

Laura M. Fiori et al.

Summary: The study identified 32 miRNAs with significantly correlated expression between the anterior cingulate cortex and habenula in individuals with major depressive disorder (MDD), where four of them showed upregulated expression. MiR-323a-3p and ERBB4 were highlighted as important factors in the pathology of MDD.

MOLECULAR PSYCHIATRY (2021)

Article Neurosciences

Identification of microRNA-9 linking the effects of childhood maltreatment on depression using amygdala connectivity

Cancan He et al.

Summary: Childhood maltreatment is considered a significant risk factor for major depressive disorder. This study investigated the neural basis of the effects of childhood maltreatment on depression, with a focus on microRNA-9. Higher miR-9 levels in MDD patients were associated with lower childhood maltreatment scores and less severe depressive symptoms, with overlapping effects on amygdala functional connectivity networks. The study also found that a support vector classifier model incorporating miR-9 levels, childhood maltreatment severity, and AFC strength could accurately differentiate MDD patients from healthy controls.

NEUROIMAGE (2021)

Review Biochemistry & Molecular Biology

The miRNome of Depression

Dariusz Zurawek et al.

Summary: Depression is a result of complex interactions between genetic, epigenetic, and environmental factors, with multiple molecular changes associated. RNA interference (RNAi) has the potential to fine-tune the overall balance of the brain, playing an important role in the development of depression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Immunology

MicroRNA-204-5p reduction in rat hippocampus contributes to stress-induced pathology via targeting RGS12 signaling pathway

Tian Lan et al.

Summary: The study identified that miR-204-5p expression was significantly down-regulated in the hippocampal dentate gyrus (DG) region of rats after chronic unpredicted stress (CUS), resulting in oxidative stress-induced neuronal damage. Overexpression of miR-204-5p alleviated oxidative stress and neuroinflammation in CUS rats by targeting RGS12, leading to improved depressive-like behaviors. Conversely, down-regulation of miR-204-5p induced neuronal deterioration and depressive-like behaviors in rats. The findings suggest that miR-204-5p plays a critical role in regulating oxidative stress damage in CUS-induced depression.

JOURNAL OF NEUROINFLAMMATION (2021)

Article Neurosciences

The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder

Wanying Liu et al.

Summary: Recent evidence suggests that miRNAs play a crucial role in the pathogenesis and treatment response of MDD, with miR-374b and miR-10a potentially serving as potential biomarkers for the disorder.

NEUROSCIENCE LETTERS (2021)

Article Biotechnology & Applied Microbiology

Expression and role of microRNA-212/nuclear factor I-A in depressive mice

Liang Si et al.

Summary: Depression is characterized by persistent depressed mood and cognitive dysfunction, severely impacting human health. The study explored the role of miR-212 in depression in mice, finding that miR-212 upregulation could ameliorate depression-like behaviors by targeting NFIA. Additionally, NFIA upregulation partially reversed the effects of miR-212 mimic in depression-like behaviors in mice.

BIOENGINEERED (2021)

Article Oncology

MiR-139-5p has an antidepressant-like effect by targeting phosphodiesterase 4D to activate the cAMP/PKA/CREB signaling pathway

Peng Huang et al.

Summary: The study revealed that miR-139-5p acts as an antidepressant by targeting PDE4D, thereby regulating the cAMP/PKA/CREB/BDNF pathway to improve depression.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Neurosciences

miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine

Jessica Mingardi et al.

Summary: Recent research has shown that decreased levels of miR-9-5p in the hippocampus is associated with vulnerability to Chronic Mild Stress (CMS) in rats, and acute subanesthetic ketamine can restore these levels in just 24 hours. The expression of miR-9-5p is inversely correlated with the anhedonic phenotype.

NEUROBIOLOGY OF STRESS (2021)

Review Cell Biology

MicroRNA regulation of prefrontal cortex development and psychiatric risk in adolescence

Alice Morgunova et al.

Summary: This review examines the role of microRNAs in adolescent PFC development and vulnerability to mental illness, highlighting the drastic changes in local microRNA expression during adolescence and the association of altered microRNA levels in the PFC with psychopathologies of adolescent onset. It suggests that non-invasive measurement of microRNAs in peripheral samples could serve as longitudinal physiological readouts of brain expression and psychiatric risk in youth.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)

Article Medicine, Research & Experimental

Abnormal expression of miR-135a in patients with depression and its possible involvement in the pathogenesis of the condition

Yinxia Ding et al.

Summary: miR-135a is significantly downregulated in patients with depression and a mouse model of depression, and its treatment in mice can reduce weight gain, increase sucrose preference, decrease immobility time in behavioral tests, inhibit hippocampal cell apoptosis, and reduce expression of inflammatory factors. Therefore, miR-135a may be a novel potential target for the treatment of depression.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Cell Biology

Neural extracellular vesicle-derived miR-17 in blood as a potential biomarker of subthreshold depression

Yusuke Mizohata et al.

Summary: Subthreshold depression (StD) is a depressive state that does not meet the criteria for major depressive disorder (MDD) but may progress to MDD, necessitating early intervention. MiR-17-5p in neural extracellular vesicles (NEVs) has shown a significant positive correlation with StD severity, suggesting its potential as a biomarker for StD.

HUMAN CELL (2021)

Article Multidisciplinary Sciences

Downregulation of miR-383 reduces depression-like behavior through targeting Wnt family member 2 (Wnt2) in rats

Shanshan Liu et al.

Summary: This study found that miR-383 plays a key role in regulating the Wnt-2 signaling pathway in a chronic stress model, it attenuates neural injury in rats by inhibiting apoptosis and inflammatory response, increasing the expression of depression-impacted proteins and neurotransmitters.

SCIENTIFIC REPORTS (2021)

Article Cell Biology

Neuroprotective effects of microRNA-211-5p on chronic stress-induced neuronal apoptosis and depression-like behaviours

Jie Shen et al.

Summary: Studies have shown that down-regulation of miR-211-5p in depressed rats leads to neuronal apoptosis and depression-like behaviors, while up-regulation of miR-211-5p has neuroprotective effects. The pathogenesis of depression may be closely related to the miR-211-5p/Dyrk1A pathway.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Neurosciences

Hippocampal miR-211-5p regulates neurogenesis and depression-like behaviors in the rat

Ye Li et al.

Summary: The study reveals that altered levels of miR-211-5p in the hippocampal DG area have a significant impact on neurogenesis, apoptosis, and depression-like behaviors in rats. Specifically, up-regulation of miR-211-5p can alleviate depression-like behaviors, reduce neuronal apoptosis, and promote neuronal regeneration; while down-regulation of miR-211-5p can induce depression-like behaviors, increase neuronal apoptosis, and decrease neuronal regeneration.

NEUROPHARMACOLOGY (2021)

Article Psychiatry

miR-98-5p plays a critical role in depression and antidepressant effect of ketamine

Chaoli Huang et al.

Summary: The study reveals that miR-98-5p plays an important role in the antidepressant mechanism of ketamine, as upregulation can alleviate depression-like behaviors and inhibition can block the antidepressant effect of ketamine. Targeting miR-98-5p may offer potential therapeutic strategies for depression treatment.

TRANSLATIONAL PSYCHIATRY (2021)

Article Behavioral Sciences

MiRNA-199a-5p targets WNT2 to regulate depression through the CREB/BDNF signaling in hippocampal neuron

Zheng Liu et al.

Summary: The study found that miR-199a-5p expression levels were significantly increased in the cerebrospinal fluids and serums of depression patients as well as in the hippocampus of chronic unpredictable mild stress (CUMS) mice. However, the expressions of WNT2, p-CREB, and BDNF were inhibited. In addition, the miR-199a-5p inhibitor enhanced certain behaviors associated with depression in CUMS mice, and this effect was attenuated by knockdown of WNT2.

BRAIN AND BEHAVIOR (2021)

Article Cell Biology

Early Life Irradiation-Induced Hypoplasia and Impairment of Neurogenesis in the Dentate Gyrus and Adult Depression Are Mediated by MicroRNA-34a-5p/T-Cell Intracytoplasmic Antigen-1 Pathway

Hong Wang et al.

Summary: Early life radiation exposure can lead to abnormal brain development and adult depression. Research on the neuropathological changes and molecular mechanisms related to depression induced by pre- or post-natal irradiation is limited. In a study on irradiated mice at postnatal day 3, miR-34a-5p and Tia1 were identified as key players in the pathogenesis of adult depression caused by gamma radiation.

CELLS (2021)

Article Medicine, Research & Experimental

MicroRNA-26a-3p rescues depression-like behaviors in male rats via preventing hippocampal neuronal anomalies

Ye Li et al.

Summary: The study revealed that miR26a-3p deficits within the hippocampal DG mediated the neuronal anomalies contributing to the display of depression-like behaviors. This miRNA may serve as a potential therapeutic target for the treatment of depression.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Genetics & Heredity

Abnormal expression profile of plasma-derived exosomal microRNAs in patients with treatment-resistant depression

Lian-Di Li et al.

Summary: In this study, dysregulated miRNAs were found in the plasma exosomes of patients with TRD, with has-miR-335-5p upregulated and has-miR-1292-3p downregulated. GO and KEGG analysis revealed that these miRNAs affect postsynaptic density, axonogenesis, and pathways related to axon formation and cell growth.

HUMAN GENOMICS (2021)

Review Neurosciences

Gut Microbiota: A Perspective for Psychiatrists

Kieran Rea et al.

NEUROPSYCHOBIOLOGY (2020)

Article Biochemistry & Molecular Biology

Podoplanin influences the inflammatory phenotypes and mobility of microglia in traumatic brain injury

Maoxing Fei et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Psychiatry

Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder

Han-ping Zhang et al.

TRANSLATIONAL PSYCHIATRY (2020)

Article Clinical Neurology

Serum Exosome-Derived miR-139-5p as a Potential Biomarker for Major Depressive Disorder

Jia-Quan Liang et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)

Article Psychiatry

Brain-enriched MicroRNA-184 is downregulated in older adults with major depressive disorder: A translational study

Ana Paula Mendes-Silva et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2019)

Article Neurosciences

Epigenetics and depression

Signe Penner-Goeke et al.

DIALOGUES IN CLINICAL NEUROSCIENCE (2019)

Article Medicine, Research & Experimental

Downregulation of microRNA-124-3p suppresses the mTOR signaling pathway by targeting DDIT4 in males with major depressive disorder

Qiuling Wang et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)

Review Neurosciences

Inflammation and depression: a causal or coincidental link to the pathophysiology?

Brian E. Leonard

ACTA NEUROPSYCHIATRICA (2018)

Article Biology

MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment

Wei-Hong Kuang et al.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2018)

Article Clinical Neurology

Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression

Yuan Fang et al.

JOURNAL OF AFFECTIVE DISORDERS (2018)

Article Allergy

MicroRNA

Thomas X. Lu et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Review Clinical Neurology

Gut Microbiota and the Neuroendocrine System

Aitak Farzi et al.

NEUROTHERAPEUTICS (2018)

Article Biochemistry & Molecular Biology

Pool size estimations for dense-core vesicles in mammalian CNS neurons

Claudia M. Persoon et al.

EMBO JOURNAL (2018)

Article Medicine, General & Internal

Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and ma-1202

Ali Gheysarzadeh et al.

JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2018)

Article Biochemistry & Molecular Biology

MiR-155 is involved in major depression disorder and antidepressant treatment via targeting SIRT1

Xun Wang et al.

BIOSCIENCE REPORTS (2018)

Review Medicine, General & Internal

Depression

Gin S. Malhi et al.

LANCET (2018)

Article Biochemistry & Molecular Biology

HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition

J. Keller et al.

MOLECULAR PSYCHIATRY (2017)

Article Multidisciplinary Sciences

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes

Juan Pablo Lopez et al.

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Altered miRNA expression network in locus coeruleus of depressed suicide subjects

Bhaskar Roy et al.

SCIENTIFIC REPORTS (2017)

Review Biochemistry & Molecular Biology

Prospective Role of MicroRNAs in Depression

Zhiying Hui et al.

CURRENT MEDICINAL CHEMISTRY (2017)

Article Neurosciences

DCC Confers Susceptibility to Depression-like Behaviors in Humans and Mice and Is Regulated by miR-218

Angelica Torres-Berrio et al.

BIOLOGICAL PSYCHIATRY (2017)

Review Gastroenterology & Hepatology

A gut (microbiome) feeling about the brain

Eoin Sherwin et al.

CURRENT OPINION IN GASTROENTEROLOGY (2016)

Article Neurosciences

MicroRNA-326 acts as a molecular switch in the regulation of midbrain urocortin 1 expression

Armaz Aschrafi et al.

JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2016)

Article Multidisciplinary Sciences

Neuro-Epigenetic Indications of Acute Stress Response in Humans: The Case of MicroRNA-29c

Sharon Vaisvaser et al.

PLOS ONE (2016)

Article Cell Biology

Amygdalar MicroRNA-15a Is Essential for Coping with Chronic Stress

Naama Volk et al.

CELL REPORTS (2016)

Review Immunology

The role of inflammation in depression: from evolutionary imperative to modern treatment target

Andrew H. Miller et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Article Clinical Neurology

Increased miR-132 level is associated with visual memory dysfunction in patients with depression

Ye Liu et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)

Review Psychiatry

Inflammation: Depression Fans the Flames and Feasts on the Heat

Janice K. Kiecolt-Glaser et al.

AMERICAN JOURNAL OF PSYCHIATRY (2015)

Review Pharmacology & Pharmacy

Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation

Anastasia I. Petra et al.

CLINICAL THERAPEUTICS (2015)

Article Psychology, Biological

A Brief History of the Development of Antidepressant Drugs: From Monoamines to Glutamate

Todd M. Hillhouse et al.

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2015)

Article Psychiatry

Comparison of plasma MicroRNA levels in drug naive, first episode depressed patients and healthy controls

Mehmet Akif Camkurt et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2015)

Review Neurosciences

Molecular mechanisms in the regulation of adult neurogenesis during stress

Martin Egeland et al.

NATURE REVIEWS NEUROSCIENCE (2015)

Article Clinical Neurology

Regulatory role of miRNAs in polyamine gene expression in the prefrontal cortex of depressed suicide completers

Juan Pablo Lopez et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)

Review Neurosciences

Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders

Sinead M. Gibney et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)

Review Behavioral Sciences

The neurobiology of depression and antidepressant action

Paul Willner et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)

Article Pharmacology & Pharmacy

The Roles of Neurotrophic Factor and Wnt Signaling in Depression

B. Voleti et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)

Article Multidisciplinary Sciences

MicroRNA Regulation of the Synaptic Plasticity-Related Gene Arc

Karin Wibrand et al.

PLOS ONE (2012)

Article Psychiatry

Phenome-transcriptome correlation unravels anxiety and depression related pathways

Philipp Gormanns et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2011)

Review Pharmacology & Pharmacy

Immune system to brain signaling: Neuropsychopharmacological implications

Lucile Capuron et al.

PHARMACOLOGY & THERAPEUTICS (2011)

Review Clinical Neurology

The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder

Courtney S. Jernigan et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)

Article Developmental Biology

Postsynaptic BDNF-TrkB Signaling in Synapse Maturation, Plasticity, and Disease

Akira Yoshii et al.

DEVELOPMENTAL NEUROBIOLOGY (2010)

Article Biochemistry & Molecular Biology

A negative regulator of MAP kinase causes depressive behavior

Vanja Duric et al.

NATURE MEDICINE (2010)

Article Neurosciences

Neural Origins of Human Sickness in Interoceptive Responses to Inflammation

Neil A. Harrison et al.

BIOLOGICAL PSYCHIATRY (2009)

Article Clinical Neurology

Reduced hippocampal neurogenesis in the GR+/- genetic mouse model of depression

Golo Kronenberg et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)

Article Biochemistry & Molecular Biology

Most mammalian mRNAs are conserved targets of microRNAs

Robin C. Friedman et al.

GENOME RESEARCH (2009)

Article Multidisciplinary Sciences

Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-γ signaling for glutamate release via a glutamate transporter

Tadahiro Numakawa et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Neurosciences

From inflammation to sickness and depression: when the immune system subjugates the brain

Robert Dantzer et al.

NATURE REVIEWS NEUROSCIENCE (2008)

Review Neurosciences

The HPA axis in major depression: classical theories and new developments

Carmine M. Pariante et al.

TRENDS IN NEUROSCIENCES (2008)

Article Psychiatry

Hippocampal volume reduction and HPA-system activity in major depression

Michael Colla et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2007)

Review Psychology, Clinical

Role of GABA in anxiety and depression

Allan V. Kalueff et al.

DEPRESSION AND ANXIETY (2007)

Review Immunology

Three or more routes for leukocyte migration into the central nervous system

RM Ransohoff et al.

NATURE REVIEWS IMMUNOLOGY (2003)

Article Psychiatry

Morning cortisol as a risk factor for subsequent major depressive disorder in adult women

TO Harris et al.

BRITISH JOURNAL OF PSYCHIATRY (2000)

Review Medicine, Research & Experimental

How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli

S Rivest et al.

PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (2000)